Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

0.7855
Delayed Data
As of Feb 24
 -0.027 / -3.32%
Today’s Change
0.54
Today|||52-Week Range
1.23
+45.46%
Year-to-Date
No recent news for Aveo Pharmaceuticals Inc.

Today’s Trading

Previous close0.81
Today’s open0.81
Day’s range0.76 - 0.83
Volume299,676
Average volume (3 months)295,542
Market cap$61.6M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+73.27%
Earnings growth (this year)-62.96%
Earnings growth (next 5 years)--
Revenue growth (last year)+4.97%
P/E ratioNM
Price/Sales3.69
Price/Book2.65

Competitors

 Today’s
change
Today’s
% change
MEIPMEI Pharma Inc+0.02+1.18%
TCONTRACON Pharmaceutica...0.000.00%
CURRCure Pharmaceutical ...0.000.00%
CAPRCapricor Therapeutic...+0.13+4.42%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 21, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$19.0M
Annual profit (last year)-$15.0M
Net profit margin-78.85%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael P. Bailey
Chief Financial Officer
Keith S. Ehrlich
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs